An mRNA-based FimH nanoparticle vaccine against uropathogenic Escherichia coli is highly immunogenic in rodents

The mRNA vaccine FimH<sub>DG</sub>-Ferritin with N1mΨ-modified nucleosides is a promising candidate for further development as a vaccine against UPEC.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-11-03
DOI
https://doi.org/10.3389/fimmu.2025.1668937
Citations
1
Primary Topic
Escherichia coli research studies
Type
article
Field-Weighted Citation Impact
1.80

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An mRNA-based FimH nanoparticle vaccine against uropathogenic Escherichia coli is highly immunogenic in rodents

Susanne Rauch, Roberto Rosini, Alfredo Pezzicoli, Roberto Adamo et al.
1 citations
Frontiers in Immunology
Escherichia coli research studies
1.80
article

An mRNA-based FimH nanoparticle vaccine against uropathogenic Escherichia coli is highly immunogenic in rodents

Susanne Rauch, Roberto Rosini, Alfredo Pezzicoli, Roberto Adamo, Sandro Roier, Benjamin Petsch, Maria Scarselli, Edith Jasny
article en
1 citations

Abstract

The mRNA vaccine FimH<sub>DG</sub>-Ferritin with N1mΨ-modified nucleosides is a promising candidate for further development as a vaccine against UPEC.

Frontiers in ImmunologyVol. 16
CureVac (Germany) (DE)
Syddansk Universitet
Openalex Percentile: Top 13%
Escherichia coli research studies
1.80
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.